37 C.F.R. § 42.23(b) limits a petitioner’s inter partes review (“IPR”) reply papers to arguments raised by the patent owner in its opposition. Under this rule, a petitioner cannot assert new invalidity arguments, cite previously unidentified parts of a prior art reference, or introduce new evidence such as a new prior art reference. The line between this and what is merely responsive, however, can be blurry. The Federal Circuit’s recent decision in Ericsson sheds some light on this line. READ MORE
The defendants in this case chose not to assert all relevant prior art patents and printed publications during an IPR (in order to increase their likelihood of joinder with an instituted IPR) and were subsequently precluded from asserting that prior art in defense to an infringement action in the Northern District of Texas. This case serves as a reminder that parties should perform a careful review of prior art patents and printed publications prior to filing or joining an IPR lest they lose their right to assert crucial prior art. READ MORE
On April 24, 2018 the Supreme Court issued two decisions that preserve Inter Partes Review (“IPR”) but dictate changes to IPR procedures. The Court, however, left room for Director Iancu to consider many options to implement changes. Read the full Client Alert here.
The Federal Circuit, sitting en banc, found that the decision of the Patent Trial and Appeal Board (“PTAB”) as to whether a petition for inter partes review (“IPR”) is barred as untimely may indeed be appealed. Wi-Fi One, LLC v. Broadcom Corp., No. 2015-1944 (Fed. Cir. Jan. 8, 2018) (en banc). This overrules the panel in Achates Reference Publishing Inc. v. Apple Inc., 803 F. 3d 652 (Fed. Cir. 2015). READ MORE
On November 21, 2017, the PTAB released its “Guidance on Motions to Amend in view of Aqua Products.” This guidance states that a Patent Owner’s motion to amend now only has to meet the requirements of 35 U.S.C. §316(d), and of 37 C.F.R. §42.121 (IPR) or 37 C.F.R. §42.221 (PGR/CBM), in order to be considered. It further states that the burden of persuasion as to patentability of substitute claims is no longer on the Patent Owner.
The guidance provides that the Board will consider all of the evidence in the record, and that if that evidence is in equipoise, then the Board will grant the motion and enter the amended claims into the patent (i.e., the burden of persuasion now lies with the Petitioner). It also says that Patent Owners have a duty under Rule 42.11 to disclose to the Board all information material to patentability of substitute claims. READ MORE
Oil States and SAS Institute appear likely to continue the Supreme Court’s practice of resolving patent cases with relatively brief unanimous (or largely unanimous) opinions that are accompanied by concurrence opinions expressing specific points. The Supreme Court started its December session with these two patent cases, and has another nine cases to hear this week. Although it is always an uncertain business to predict outcomes from attending oral arguments, the view in the post-argument hallway was that the Supreme Court would maintain the status quo. READ MORE
Join Law.com IP reporter Scott Graham and Orrick, Herrington & Sutcliffe partner Mark Davies on a conference call for day-after analysis of Supreme Court arguments in Oil States and SAS Institute, two cases that could reshape inter partes review proceedings or wipe them out altogether. Scott and Mark will share their takeaways from inside the chamber, answer your questions, and discuss strategies for litigating patents until the clouds clear.
This conference call (9 AM PST/ 12 PM EST, Tuesday November 28) is free. Please register here.
Mark Davies leads Orrick’s Patent Appeal Working Group and is D.C. head of the firm’s Supreme Court and Appellate practice. He represents clients in appeals that include Patent Trial and Appeal Board decisions and is the author of Patent Appeals: The Elements of Effective Advocacy in the Federal Circuit (Matthew Bender 2018).
During inter partes review proceedings, the Patent Trial and Appeal Board (“PTAB”) is required to give claims their broadest reasonable construction in light of the specification. See 37 C.F.R. § 42.100(b). Thus, when the PTAB imports claim limitations based on the invention’s preferred embodiments, its decision upholding patent validity may be subject to reversal. In situations where a broader construction is argued by the petitioner and adopted in the Institution Decision, and the patent owner does not provide suitable arguments for nonobviousness in light of that broader construction, the Federal Circuit may choose to reverse rather than remand. READ MORE
Much like death and taxes, USPTO fee increases are a sure thing. On November 14, 2017, the USPTO issued a new final rule raising many of the fees charged by the Office. The Office also provided a chart that shows the changes from the current fees.
While many fees are increasing, the largest fee increase was to the IPR filing fees. As set forth below, IPR fees are going up as much as 72%, and CBM/PGR fees as much as 33%.
(USPTO Final Rule: At-a-Glance, p. 17, available here)
The out-the-door fees for filing a basic IPR will go up from $23,000 to $30,500.
The out-the-door fees for filing a basic CBM/PGR rises from $30,000 to $38,000.
Excess claims fees in all of these proceedings are also going up by 50%. For IPRs, the fees go from $200 to $300 per claim over 20 for the filing fee, and from $400 to $600 per claim over 15 for the institution fee. For CBM/PGR, the fees go from $250 to $375 per claim over 20 for the filing fee, and from $550 to $825 per claim over 15 for the institution fee.
These new fees go into effect on January 16, 2018.
On Tuesday, November 7, 2017, the USPTO published its final rule clarifying the situations in which the Office will recognize the existence of the attorney-client privilege in proceedings before the PTAB. New section 37 C.F.R. 42.57 provides that all communications between a client and a USPTO patent practitioner (i.e. a registered attorney or agent), or between a client and a person authorized under foreign law to provide legal advice on patent matters, which communications are within the scope of the practitioner’s authority, will be afforded the attorney-client privilege. READ MORE